|
| |
Image Results
Loading...
Loading...
EMEND Pages on BioPortfolio:
|
Scientia Veritas Reports
The program also paid off with approvals of Janumet and Isentress in 2007 and a new formulation of Emend in January 2008. Merck's future depends on its ...
http://www.bioportfolio.com/cgi-bin/acatalog/Scientia_Verita...
|
Biotechnology News TRAL Search
For EMEND, ths technology advance elmnates a food reqrement and mproves oavalalty y 600%. EMEND was confrmed to e effectve for. ...
http://www.bioportfolio.co.uk/TRAL-news.htm...
|
BioPortfolio - Wolters Kluwer Health - Profile
Aprepitant (Emend) is a neurokinin-1 (NK(1)) receptor antagonist that is...2nd September, 2009. Wolters Kluwer Health, Adis, 41 Centorian Drive, ...
http://www.bioportfolio.com/biocorporate/32033-Wolters%25252...
|
BioPortfolio's Approved Drugs News by Tradename - E
EMEND · EMGEL · EMLA · EMPRACET · EMSAM · EMTRICITABINE · EMTRIVA · E-MYCIN · ENABLEX · ENALAPRIL_MALEATE · ENALAPRILAT ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...
|
The Cancer Market Outlook to 2009
Emend 180. Bisphosphonates 181. Drug analysis 182. Zometa 182. Aredia 185 HGFs 185. Drug analysis 186. Procrit/Eprex 186. Epogen and Aranesp 187 ...
http://www.bioportfolio.com/news/datamonitor_92.htm...
|
BioPortfolio - Spirurida - InDepth
Iraq, with a redescription of R. tigridis Rahemo, 1978 (emend.). Two species of Rhabdochona Railliet, 1916 (Nematoda: Rhabdochonidae) were...10th November, ...
http://www.bioportfolio.com/indepth/Spirurida.pdf...
|
Oncology Market Forecast to 2015 (TA225)
Emend (aprepitant) (Merck). * Rezonic (casopitant) (GSK). * Zofran (ondansetron) (GSK). Neutropenia. * Leukine (sargramostim) (Genzyme, Bayer) ...
http://www.bioportfolio.com/cgi-bin/ss000001.pl?PRODREF=2278...
| Results from other life science and pharmaceutical sites:
EMEND®
Each capsule of EMEND for oral administration contains either 40 mg, 80 mg, ... Following oral administration of a single 40 mg dose of EMEND in the fasted ...
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_...
|
Aprepitant - Wikipedia, the free encyclopedia
Aprepitant is manufactured by Merck & Co. under the brand name Emend for prevention ... The active substance of Emend is aprepitant, which is effective
in ...
http://en.wikipedia.org/wiki/Aprepitant...
|
EMEND .
EMEND for Injection is a lyophilized prodrug of aprepitant containing ... Each vial of EMEND for Injection for intravenous administration contains 188 mg of
...
http://www.merck.com/product/usa/pi_circulars/e/emend_iv/eme...
|
ACS :: New Anti-Nausea Drug Approved For Chemotherapy Patients
7 Apr 2003 ... The Food and Drug Administration has approved the drug Emend (aprepitant), manufactured by Merck, to help control the nausea and vomiting ...
http://www.cancer.org/docroot/NWS/content/NWS_2_1x_New_Anti-...
|
9840004 Patient Information EMEND (fosaprepitant dimeglumine) for ...
Read the Patient Information that comes with EMEND (fosaprepitant ... are allergic to fosaprepitant or any of the ingredients in EMEND for Injection. ...
http://www.merck.com/product/usa/pi_circulars/e/emend_iv/eme...
|
EMEND (fosaprepitant dimeglumine) injection, powder, lyophilized ...
EMEND1 (fosaprepitant dimeglumine) for Injection is a sterile, lyophilized prodrug of aprepitant and is chemically described as ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=9332...
|
• are taking any of the following medicines:
Read the Patient Information that comes with EMEND before you take it and each time you ... Taking EMEND with any of these medicines could cause serious or ...
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_...
|
Emend (aprepitant) Capsules
11 Jul 2009 ... Emend, when given as a 40-mg single oral dose Day 1, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 8% on Day 2, 16% on Day 4, ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
emend (aprepitant) capsule emend (aprepitant) [Merck & Co ...
Each capsule of EMEND for oral administration contains either 40 mg, 80 mg or 125 mg of aprepitant and the following inactive ingredients: sucrose, ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=7355...
|
FDA Safety Changes: Boniva, Emend, Clozaril
25 Feb 2009 ... The FDA has approved revisions to the safety labeling for ibandronate sodium tablets (Boniva), aprepitant capsules (Emend), and clozapine ...
http://www.medscape.com/viewarticle/588759...
|
|
